IV thrombolysis and statins
- PMID: 21849650
- DOI: 10.1212/WNL.0b013e31822c9135
IV thrombolysis and statins
Abstract
Objective: To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in stroke patients receiving IV thrombolysis (IVT).
Methods: In a pooled observational study of 11 IVT databases, we compared outcomes between statin users and nonusers. Outcome measures were excellent 3-month outcome (modified Rankin scale 0-1) and ICH in 3 categories. We distinguished all ICHs (ICH(all)), symptomatic ICH based on the criteria of the ECASS-II trial (SICH(ECASS-II)), and symptomatic ICH based on the criteria of the National Institute of Neurological Disorders and Stroke (NINDS) trial (SICH(NINDS)). Unadjusted and adjusted odds ratios (OR) with 95% confidence intervals were calculated.
Results: Among 4,012 IVT-treated patients, 918 (22.9%) were statin users. They were older, more often male, and more frequently had hypertension, hypercholesterolemia, diabetes, coronary heart disease, and concomitant antithrombotic use compared with nonusers. Fewer statin users (35.5%) than nonusers (39.7%) reached an excellent 3-month outcome (OR(unadjusted) 0.84 [0.72-0.98], p = 0.02). After adjustment for age, gender, blood pressure, time to thrombolysis, and stroke severity, the association was no longer significant (0.89 [0.74-1.06], p = 0.20). ICH occurred by trend more often in statin users (ICH(all) 20.1% vs 17.4%; SICH(NINDS) 9.2% vs 7.5%; SICH(ECASS-II) 6.9% vs 5.1%). This difference was statistically significant only for SICH(ECASS-II) (OR = 1.38 [1.02-1.87]). After adjustment for age, gender, blood pressure, use of antithrombotics, and stroke severity, the OR(adjusted) for each category of ICH (ICH(all) 1.15 [0.93-1.41]; SICH(ECASS-II) 1.32 [0.94-1.85]; SICH(NINDS) 1.16 [0.87-1.56]) showed no difference between statin users and nonusers.
Conclusion: In stroke patients receiving IVT, prior statin use was neither an independent predictor of functional outcome nor ICH. It may be considered as an indicator of baseline characteristics that are associated with a less favorable course.
Similar articles
-
Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.Neurology. 2011 Jul 26;77(4):341-8. doi: 10.1212/WNL.0b013e3182267b8c. Epub 2011 Jun 29. Neurology. 2011. PMID: 21715707
-
Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.Cerebrovasc Dis. 2012;33(2):135-40. doi: 10.1159/000334186. Epub 2011 Dec 14. Cerebrovasc Dis. 2012. PMID: 22179586
-
Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.Cerebrovasc Dis. 2012;33(4):362-8. doi: 10.1159/000335840. Epub 2012 Mar 14. Cerebrovasc Dis. 2012. PMID: 22433177
-
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis.Neurology. 2020 Jul 14;95(2):e121-e130. doi: 10.1212/WNL.0000000000009756. Epub 2020 Jun 17. Neurology. 2020. PMID: 32554767
-
Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis.Neurol Sci. 2019 Nov;40(11):2267-2275. doi: 10.1007/s10072-019-03995-0. Epub 2019 Jul 2. Neurol Sci. 2019. PMID: 31267305
Cited by
-
Statin Use and Outcomes of Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.Front Neurol. 2021 Sep 22;12:734927. doi: 10.3389/fneur.2021.734927. eCollection 2021. Front Neurol. 2021. PMID: 34630305 Free PMC article.
-
Hemorrhagic transformation after cerebral infarction: current concepts and challenges.Ann Transl Med. 2014 Aug;2(8):81. doi: 10.3978/j.issn.2305-5839.2014.08.08. Ann Transl Med. 2014. PMID: 25333056 Free PMC article. Review.
-
Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):897-905. doi: 10.1002/pds.3828. Epub 2015 Jul 14. Pharmacoepidemiol Drug Saf. 2015. PMID: 26175179 Free PMC article.
-
Recanalisation therapy in patients with acute ischaemic stroke caused by large artery occlusion: choice of therapeutic strategy according to underlying aetiological mechanism?Stroke Vasc Neurol. 2017 Aug 1;2(4):244-250. doi: 10.1136/svn-2017-000090. eCollection 2017 Dec. Stroke Vasc Neurol. 2017. PMID: 29507785 Free PMC article. Review.
-
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use.Sci Rep. 2022 Sep 14;12(1):15478. doi: 10.1038/s41598-022-19852-8. Sci Rep. 2022. PMID: 36104394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical